- Sirolimus, also
known as
rapamycin and sold
under the
brand name
Rapamune among others, is a
macrolide compound that is used to coat
coronary stents, prevent...
- drug
Rapamune.
Wyeth is
targeted in the suit for off-label marketing,
targeting specific doctors and
medical facilities to
increased sales of
Rapamune, trying...
-
marketed sirolimus (
Rapamune) for off-label uses,
targeted specific doctors and
medical facilities to
increase sales of
Rapamune,
tried to get transplant...
-
Immunosuppressants ciclosporin (Sandimmune Neoral)
tacrolimus (Prograf)
sirolimus (
Rapamune)
mercaptopurine Sedatives, hypnotics, and
anxiolytics buspirone (Buspar)...
-
treat metastatic pancreatic cancer, was
approved by FDA in
October 2015.
Rapamune is a nanocrystal-based drug that was
approved by the FDA in 2000 to prevent...
- (INN)
Raniviz ranolazine (INN)
ranpirnase (INN)
rapacuronium bromide (INN)
Rapamune Raplon rasagiline (INN, USAN)
rasburicase (INN)
raseglurant (INN) rathyronine...
- and has less
pronounced side-effects.
Sirolimus (rapamycin,
trade name
Rapamune) is a
macrolide lactone,
produced by the
actinomycete bacterium Streptomyces...
-
proper cell
growth and proliferation.
Sirolimus (rapamycin,
trade name
Rapamune) is a
macrolide compound. It has
immunosuppressant and antiproliferative...
-
criminal and
civil liability arising from the
unlawful marketing of its drug
Rapamune for uses that were not FDA-approved and
potentially harmful. The case,...
- settlement), and with
Pfizer Inc. (over
allegations of
unlawful promotion of
Rapamune; Arizona's
share was $721,169 out of the
nationwide $35
million settlement)...
